Hello,

I'm curious if any institutes which utilize repeater pumps for compounding have any experience or thoughts on the following:

- For repeater pumps with selectable flow rates, what is your institution's preferred setting (e.g., low, medium, high).?
- Have you noticed any variations in volumes when utilizing higher flow rates?
- What is your expected and/or tolerance for variation when utilizing repeater pumps?
- How frequently do you recalibrate your repeater pumps (e.g., daily, after a certain number of pumps, etc.)

Thank you,
T.J.

Does anyone use a process (committee approval vs decision tree vs expert opinion) for evaluating whether something should be built as a physical kit, virtual kit, or just stocked in an Omnicell?

Ideally, this looks like some sort of objective decision tree based on the situation you are evaluating, but hoping someone else might have built this before we explore it for our health system.

Thanks!

Hi all-- would you please let me know if you are requiring tele-monitoring for IV lacosamide? Thanks in advance.

For those hospitals who begun using Beyfortus for RSV season and procure your supply via Vaccine For Children program.
Do you know of any requirements for data transmission/collection/reporting back to the program. For vaccines it is easy, but Beyfortus is a monoclonal antibody with CVX code. Strange combination, struggling to find answers.
Thanks.

We recently had a situation where a patient adjusted the rate in the IV pump of a medication they were receiving. It is not standard practice to lock the programming of the IV pumps. Does anyone have standards on locking the programming of IV pumps or any guidance around that? Thanks.

Does anyone have a successful way of encouraging documentation of near miss events in an ambulatory setting? Our Specialty Pharmacy has a quality initiative to improve near miss reporting with discussions currently centered around tying reports to the team member annual evaluation. I want to discourage this so looking for alternative solutions to recommend. Thank you!

Hello!

Our institution received an advisory that DEHP was found in the tubing labeled non-DEHP for Alaris pumps above the historical <0.1% threshold. Our institution relies primarily on alaris pumps and have limited options for alternatives.

How are you handling the tubing advisory?
What are you doing for the special populations (neonates, etc)?
How are you infusing medications that require non-DEHP tubing?

Thank you for any ideas you may have!

Good afternoon,

For sites that draw up antibiotic syringes from Samson bags -- anyone notice any particulate matter/coring with this product once reconstituted?

Thank you!

We utilize Kitcheck and have had errors related to used medications being left in kits and sent back out. Looking to see what others are doing and to see if anyone has discovered a way to reliably stop this from happening.

Yale-New Haven Hospital PGY2 Medication Use Safety and Policy residency program will be hosting two information sessions:

Tuesday 10/24 at 5:00 PM EST
Thursday 11/16 at 5:00 PM EST

Follow this link to register: https://keysurvey.ynhh.org/f/41685002/15e5/